APGE
Price
$135.07
Change
-$0.01 (-0.01%)
Updated
Sep 2 closing price
Capitalization
10.22B
67 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$28.49
Change
-$0.57 (-1.96%)
Updated
Sep 9 closing price
Capitalization
3.63B
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs RCUS

APGE vs RCUS Comparison Chart in %
View a ticker or compare two or three
VS
APGE vs. RCUS commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 10, 2026
Stock price -- (APGE: $135.07 vs. RCUS: $28.49)
Brand notoriety: APGE and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 367% vs. RCUS: 165%
Market capitalization -- APGE: $10.22B vs. RCUS: $3.63B
APGE [@Biotechnology] is valued at $10.22B. RCUS’s [@Biotechnology] market capitalization is $3.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $132.08B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 3 bearish.
  • RCUS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than RCUS.

Price Growth

APGE (@Biotechnology) experienced а 0.00% price change this week, while RCUS (@Biotechnology) price change was -4.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.96%. For the same industry, the average monthly price growth was -1.95%, and the average quarterly price growth was +2729.16%.

Reported Earning Dates

APGE is expected to report earnings on Nov 16, 2026.

RCUS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($10.2B) has a higher market cap than RCUS($3.63B). APGE YTD gains are higher at: 78.948 vs. RCUS (19.555). APGE has higher annual earnings (EBITDA): -303.65M vs. RCUS (-439M). APGE has more cash in the bank: 1.06B vs. RCUS (702M). APGE has less debt than RCUS: APGE (8.05M) vs RCUS (114M). RCUS has higher revenues than APGE: RCUS (117M) vs APGE (0).
APGERCUSAPGE / RCUS
Capitalization10.2B3.63B281%
EBITDA-303.65M-439M69%
Gain YTD78.94819.555404%
P/E RatioN/AN/A-
Revenue0117M-
Total Cash1.06B702M151%
Total Debt8.05M114M7%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGERCUS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 29 days ago
66%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
APGE
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SRLN40.52-0.02
-0.05%
State Street® Blackstone Senior Loan ETF
BAMY27.11-0.04
-0.15%
Brookstone Yield ETF
USEP41.92-0.12
-0.29%
Innovator US Equity Ultra Buffer ETF-Sep
TDVI31.52-0.15
-0.47%
FT Vest Tech Div Trgt Inc ETF
LTL23.85-0.39
-1.61%
ProShares Ultra Communication Services

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with DFTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then DFTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
N/A
DFTX - APGE
50%
Loosely correlated
-0.63%
BOLD - APGE
49%
Loosely correlated
-0.35%
ORKA - APGE
48%
Loosely correlated
-2.98%
SYRE - APGE
47%
Loosely correlated
-4.25%
RCUS - APGE
39%
Loosely correlated
-1.96%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-1.96%
VIR - RCUS
49%
Loosely correlated
-3.31%
XNCR - RCUS
49%
Loosely correlated
-1.54%
DYN - RCUS
46%
Loosely correlated
-5.51%
AURA - RCUS
44%
Loosely correlated
-2.17%
KURA - RCUS
44%
Loosely correlated
-3.43%
More